Literature DB >> 11723251

Regulation of flavin-containing monooxygenase 1 expression by ying yang 1 and hepatic nuclear factors 1 and 4.

Z Luo1, R N Hines.   

Abstract

The flavin-containing monooxygenases (FMOs) are important for the oxidation of a variety of environmental toxicants, natural products, and therapeutics. Consisting of six family members (FMO1-5), these enzymes exhibit distinct but broad and overlapping substrate specificity and are expressed in a highly tissue- and species-selective manner. Corresponding to previously identified regulatory domains, a YY1 binding site was identified at the major rabbit FMO1 promoter, position -8 to -2, two overlapping HNF1alpha sites, position -132 to -105, and two HNF4alpha sites, position -467 to -454 and -195 to -182. Cotransfection studies with HNF1alpha and HNF4alpha expression vectors demonstrated a major role for each of these factors in enhancing FMO1 promoter activity. In contrast, YY1 was shown by site-directed mutagenesis to be dispensable for basal promoter activity but suppressed the ability of the upstream domains to enhance transcription. Finally, comparisons between rabbit and human FMO1 demonstrated conservation of each of these regulatory elements. With the exception of the most distal HNF4alpha site, each of the orthologous human sequences also was able to compete with rabbit FMO1 cis-elements for specific protein binding. These data are consistent with these same elements being important for regulating human FMO1 developmental- and tissue-specific expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11723251     DOI: 10.1124/mol.60.6.1421

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

Review 1.  Flavin-containing monooxygenases in aging and disease: Emerging roles for ancient enzymes.

Authors:  Ryan Rossner; Matt Kaeberlein; Scott F Leiser
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

2.  Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide, a proatherogenic metabolite of choline and L-carnitine.

Authors:  Jaana Hartiala; Brian J Bennett; W H Wilson Tang; Zeneng Wang; Alexandre F R Stewart; Robert Roberts; Ruth McPherson; Aldons J Lusis; Stanley L Hazen; Hooman Allayee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03-27       Impact factor: 8.311

Review 3.  HNF4α--role in drug metabolism and potential drug target?

Authors:  Wendy W Hwang-Verslues; Frances M Sladek
Journal:  Curr Opin Pharmacol       Date:  2010-12       Impact factor: 5.547

4.  Aryl hydrocarbon receptor-dependent induction of flavin-containing monooxygenase mRNAs in mouse liver.

Authors:  Trine Celius; Steven Roblin; Patricia A Harper; Jason Matthews; Paul C Boutros; Raimo Pohjanvirta; Allan B Okey
Journal:  Drug Metab Dispos       Date:  2008-09-02       Impact factor: 3.922

5.  Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation models.

Authors:  Jun Zhang; Madhusudana R Chaluvadi; Rob Reddy; Meike S Motika; Terrilyn A Richardson; John R Cashman; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2008-12-16       Impact factor: 3.922

6.  Effects of salinity acclimation on the pesticide-metabolizing enzyme flavin-containing monooxygenase (FMO) in rainbow trout (Oncorhynchus mykiss).

Authors:  Ramon Lavado; Rosaura Aparicio-Fabre; Daniel Schlenk
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2012-09-06       Impact factor: 3.228

7.  Osmotic regulation of a novel flavin-containing monooxygenase in primary cultured cells from rainbow trout (Oncorhynchus mykiss).

Authors:  Gabriela Rodríguez-Fuentes; Rosaura Aparicio-Fabre; Qi Li; Daniel Schlenk
Journal:  Drug Metab Dispos       Date:  2008-03-27       Impact factor: 3.922

8.  Alternative promoters and repetitive DNA elements define the species-dependent tissue-specific expression of the FMO1 genes of human and mouse.

Authors:  Elizabeth A Shephard; Pritpal Chandan; Milena Stevanovic-Walker; Mina Edwards; Ian R Phillips
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.